What have we learnt about the regulation of phosphate metabolism?

被引:19
作者
Blumsohn, A [1 ]
机构
[1] Univ Sheffield, Acad Unit Bone Metab, Div Clin Sci N, Sheffield S5 7AU, S Yorkshire, England
关键词
adaptation to phosphate intake; fibroblast growth factor 23; PHEX; phosphatonin;
D O I
10.1097/01.mnh.0000133983.40182.c3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The search for hormones which specifically regulate phosphate metabolism has fuelled recent tantalizing studies. These studies have been motivated by diseases involving renal phosphate wasting, including tumor-induced osteomalacia, X-linked hypophosphatemic rickets, and autosomal dominant hypophosphatemia. This review focuses on likely candidate lphosphatonins' and their possible physiological significance. Recent findings Candidate phosphatonins include fibroblast growth factor 23, matrix extracellular phosphoglycoprotein, stanniocalcin, and Frizzled-related protein 4. Fibroblast growth factor 23 has emerged as the prime candidate explaining pathophysiology of these diseases. FGF-23 is expressed in most tumors in tumor-induced osteomalacia. Serum fibroblast growth factor 23 is increased in most patients with X-linked hypophosphatemic rickets and tumor-induced osteomalacia. Injection of recombinant fibroblast growth factor 23 induces phosphaturia, hypophosphatemia, and suppression of 1,25-dihydroxyvitamin D in animals. Many unanswered questions remain, including the relationship between PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) mutations and elevated fibroblast growth factor 23. It is also not clear whether these candidate phosphatonins play a role in phosphate or vitamin D metabolism in healthy humans, or that this role is endocrine. The most compelling evidence derives from the fibroblast growth factor 23-knockout mouse which shows hyperphosphatemia and increased serum 1,25-dihydroxyvitamin D. A physiologically relevant phosphatonin should explain renal adaptation to variable dietary phosphate intake. The tissue source and determinants of serum fibroblast growth factor 23 are unknown. Summary Pathophysiological and animal studies serve as a logical foundation on which to base further questions of human physiology. The definition of what is or is not a phosphatonin may need to be refined. There is a need to return to 'old-fashioned' human physiology studies to place recent findings in perspective.
引用
收藏
页码:397 / 401
页数:5
相关论文
共 51 条
  • [1] Allen HC, 2003, J BONE MINER RES, V18, P1375
  • [2] Involvement of the MAPK-kinase pathway in the PTH-mediated regulation of the proximal tubule type IIa Na+/Pi cotransporter in mouse kidney
    Bacic, D
    Schulz, N
    Biber, J
    Kaissling, B
    Murer, H
    Wagner, CA
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 446 (01): : 52 - 60
  • [3] The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
    Bai, XY
    Miao, DS
    Goltzman, D
    Karaplis, AC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 9843 - 9849
  • [4] Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent
    Berndt, T
    Craig, TA
    Bowe, AE
    Vassiliadis, J
    Reczek, D
    Finnegan, R
    De Beur, SMJ
    Schiavi, SC
    Kumar, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) : 785 - 794
  • [5] FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate
    Bowe, AE
    Finnegan, R
    de Beur, SMJ
    Cho, J
    Levine, MA
    Kumar, R
    Schiavi, SC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (04) : 977 - 981
  • [6] Human recombinant endopeptidase PHEX has a strict S1′ specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein
    Campos, M
    Couture, C
    Hirata, IY
    Juliano, MA
    Loisel, TP
    Crine, P
    Juliano, L
    Boileau, G
    Carmona, AK
    [J]. BIOCHEMICAL JOURNAL, 2003, 373 : 271 - 279
  • [7] Oncogenic osteomalacia - A complex dance of factors
    Carpenter, TO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) : 1705 - 1708
  • [8] Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2
    Chau, H
    El-Maadawy, S
    McKee, MD
    Tenenhouse, HS
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (04) : 644 - 657
  • [9] Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism
    De Beur, SMJ
    Finnegan, RB
    Vassiliadis, J
    Cook, B
    Barberio, D
    Estes, S
    Manavalan, P
    Petroziello, J
    Madden, SL
    Cho, JY
    Kumar, R
    Levine, MA
    Schiavi, SC
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (06) : 1102 - 1110
  • [10] PHEX gene and hypophosphatemia
    Drezner, MK
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (01) : 9 - 18